The United States Human Microbiome Market size is reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031.
United States Human Microbiome Market By Application
- Therapeutics
- Diagnostic Applications
- Probiotics
- Prebiotics
- Food & Beverages
The United States human microbiome market is segmented by application into several key segments. Therapeutics segment includes products aimed at treating conditions such as gastrointestinal disorders, infections, and autoimmune diseases by modulating the microbiome. Diagnostic applications involve the use of microbiome analysis for disease detection, biomarker identification, and personalized medicine.
Probiotics are beneficial microorganisms introduced to the body for health benefits, commonly used in supplements and functional foods. Prebiotics are substances that promote the growth of beneficial bacteria in the gut, often used in dietary supplements. The food and beverages segment encompasses microbiome-based products incorporated into daily diet routines for health enhancement, including fortified foods and drinks.